Brooks Laboratories Share PriceBrooks Laboratories

₹90.85
-1.85 (-2%)
As on 27 September, 2023 | 17:33 BSE: 533543 NSE: BROOKSISIN: INE650L01011

Brooks Laboratories Performance

Day Range

  • Low 89
  • High 94
90.85

52 Week Range

  • Low 56.95
  • High 127.58
90.85
  • Open Price93.95
  • Previous Close92.7
  • Volume159187

Start SIP in Brooks Laboratories

Start SIP

Brooks Laboratories Share Price

  • Over 1 Month -5.36%
  • Over 3 Month 23.61%
  • Over 6 Month 24.2%
  • Over 1 Year -19.79%

Brooks Laboratories Key Statistics

P/E Ratio -10.4
PEG Ratio -1.1
Market Cap Cr 239
Price to Book Ratio 3.2
EPS -3.1
Dividend 0
Relative Strength Index 37.23
Money Flow Index 44.3
MACD Signal 1.92
Average True Range 3.26

Brooks Laboratories Investment Rating

  • Master Rating:
  • Brooks Laboratories has an operating revenue of Rs. 61.70 Cr. on a trailing 12-month basis. An annual revenue de-growth of -31% needs improvement, Pre-tax margin of -55% needs improvement, ROE of -28% is poor and needs improvement. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 7% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 26 which is a POOR score indicating inconsistency in earnings, a RS Rating of 43 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at A- which is evident from recent demand for the stock, Group Rank of 92 indicates it belongs to a poor industry group of Medical-Generic Drugs and a Master Score of C is fair but needs to improve. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

EPS Strength

Price Strength

Buyer Demand

Group Rank

Brooks Laboratories Financials
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 161312161521
Operating Expenses Qtr Cr 161313161921
Operating Profit Qtr Cr 00-10-40
Depreciation Qtr Cr 000000
Interest Qtr Cr 000000
Tax Qtr Cr 000000
Net Profit Qtr Cr -1-1-2-1-50
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 5678
Operating Expenses Annual Cr 6175
Operating Profit Annual in Cr -62
Depreciation Cr 21
Interest Annual Cr 11
Tax Annual Cr 00
Net Profit Annual Cr -81
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr 3
Cash from Investing Activity Annual Cr 1
Cash from Financing Annual Activity Cr -4
Net Cash Flow Annual Cr 0
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 5765
Fixed Assets Annual Cr 1516
Total Non Current Assets Annual Cr 6566
Total Current Assets Annual Cr 2837
Total Assets Annual Cr 92103
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 2326
ROE Annual % -141
ROCE Annual % -122
Total Debt to Total Equity Annual --
EBDIT Annual Margin % -104
IndicatorJun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022
Oper Rev Qtr Cr 161315181728
Operating Expenses Qtr Cr 161324272632
Operating Profit Qtr Cr 00-9-9-9-4
Depreciation Qtr Cr 002222
Interest Qtr Cr 001111
Tax Qtr Cr 00-2-4-2-1
Net Profit Qtr Cr -4-4-9-5-9-4
IndicatorMar 2023Mar 2022
Total Revenue Annual Cr 6392
Operating Expenses Annual Cr 90105
Operating Profit Annual in Cr -26-14
Depreciation Cr 77
Interest Annual Cr 23
Tax Annual Cr -7-5
Net Profit Annual Cr -21-16
IndicatorMar 2023Mar 2022
Cash from Operating Activity Annual Cr -37
Cash from Investing Activity Annual Cr -25
Cash from Financing Annual Activity Cr 64
Net Cash Flow Annual Cr 2
IndicatorMar 2023Mar 2022
Total ShareHolders Funds Annual Cr 7463
Fixed Assets Annual Cr 15125
Total Non Current Assets Annual Cr 82135
Total Current Assets Annual Cr 2861
Total Assets Annual Cr 110196
IndicatorMar 2023Mar 2022
Book Value Per Share Annual Rs 3054
ROE Annual % -28-26
ROCE Annual % -43-14
Total Debt to Total Equity Annual --
EBDIT Annual Margin % -41-15

Brooks Laboratories Technicals

EMA & SMA

Current Price
₹90.85
-1.85 (-2%)
  • Bullish Moving Average
  • ___
  • 5
  • Bearish Moving Average
  • ___
  • 11
  • 20 Day
  • ₹99.97
  • 50 Day
  • ₹95.28
  • 100 Day
  • ₹89.33
  • 200 Day
  • ₹88.11
  • 20 Day
  • ₹101.79
  • 50 Day
  • ₹96.18
  • 100 Day
  • ₹81.92
  • 200 Day
  • ₹85.89

Brooks Laboratories Resistance and Support

PIVOT
₹94.07
Resistance
First Resistance ₹98.09
Second Resistance ₹103.47
Third Resistance ₹107.49
RSI 37.23
MFI 44.3
MACD Single Line 1.92
MACD -0.11
Support
First Resistance ₹88.69
Second Resistance ₹84.67
Third Resistance ₹79.29

Brooks Laboratories Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 95,866 9,586,600 100
Week 33,617 3,361,740 100
1 Month 34,124 3,412,433 100
6 Month 72,178 4,760,148 65.95

Brooks Laboratories Result Highlights

Brooks Laboratories Synopsis

NSE-Medical-Generic Drugs

Brooks Laboratories is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 55.54 Cr. and Equity Capital is Rs. 24.70 Cr. for the Year ended 31/03/2023. Brooks Laboratories Ltd. is a Public Limited Listed company incorporated on 23/01/2002 and has its registered office in the State of Himachal Pradesh, India. Company’s Corporate Identification Number(CIN) is L24232HP2002PLC000267 and registration number is 000267.
Market Cap 238
Sales 56
Shares in Float 0.94
No of funds 1
Yield
Book Value 4.07
U/D Vol ratio 1.9
LTDebt / Equity
Alpha -0.05
Beta 0.62

Brooks Laboratories

Owner NameAug-23Jun-23Mar-23Dec-22
Promoters 63.59%66.41%66.41%66.41%
Mutual Funds 1.25%
Foreign Portfolio Investors
Individual Investors 27.8%27.84%27.72%27.8%
Others 7.36%5.75%5.87%5.79%

Brooks Laboratories Management

Name Designation
Mr. Atul Ranchal Chairman
Mr. Rajesh Mahajan Managing Director
Mr. Manpreet Singh Naroo Director - Technical
Ms. Sonia Gupta Independent Director
Mr. Deepak Mahajan Independent Director
Mr. Rajnish Kumar Bedi Independent Director

Brooks Laboratories Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Brooks Laboratories Corporate Action

Date Purpose Remarks
2023-08-10 Quarterly Results
2023-07-18 Rights issue of Equity Shares
2023-07-11 Rights issue of Equity Shares
2023-05-29 Audited Results
2023-02-14 Quarterly Results

Brooks Laboratories MF Shareholding

Name Amount(cr)
Quant ESG Equity Fund Regular Growth 192
Quant Healthcare Fund Regular Growth 137
  • Company Name
  • CMP
  • Chg(%)
  • Company Name
  • CMP
  • Chg(%)

Brooks Laboratories FAQs

What is Share Price of Brooks Laboratories ?

Brooks Laboratories share price is ₹90 As on 27 September, 2023 | 17:19

What is the Market Cap of Brooks Laboratories ?

The Market Cap of Brooks Laboratories is ₹238.5 Cr As on 27 September, 2023 | 17:19

What is the P/E ratio of Brooks Laboratories ?

The P/E ratio of Brooks Laboratories is -10.4 As on 27 September, 2023 | 17:19

What is the PB ratio of Brooks Laboratories ?

The PB ratio of Brooks Laboratories is 3.2 As on 27 September, 2023 | 17:19

Q2FY23